123 related articles for article (PubMed ID: 1697132)
21. Lack of evidence of hepatitis D (delta) infection in Newfoundland and Labrador.
Ratnam S; Head CB; Butler RW
CMAJ; 1986 Apr; 134(8):905-7. PubMed ID: 3955485
[TBL] [Abstract][Full Text] [Related]
22. [Delta agent in a Chilean population HBsAg carrier].
Velasco M; Brahm J; Ponzetto A
Rev Med Chil; 1985 Jan; 113(1):3-5. PubMed ID: 4081382
[No Abstract] [Full Text] [Related]
23. A review of the efficacy of adenine arabinoside and lymphoblastoid interferon in the Royal Free Hospital studies of hepatitis B virus carrier treatment: identification of factors influencing response rates.
Thomas HC; Scully LJ; Lever AM; Yap I; Pignatelli M
Infection; 1987; 15 Suppl 1():S26-31. PubMed ID: 2439462
[TBL] [Abstract][Full Text] [Related]
24. [Prevalence of anti-delta antibodies in HBsAg carriers].
Söyletir G; Babacan F; Göral M; Can A
Mikrobiyol Bul; 1989 Apr; 23(2):97-101. PubMed ID: 2626106
[TBL] [Abstract][Full Text] [Related]
25. Identification of factors influencing response rate to antiviral therapy of chronic hepatitis B virus infection. A review of the efficacy of adenine arabinoside and lymphoblastoid interferon in the Royal Free Hospital studies.
Scully LJ; Lever AM; Yap I; Pignatelli M; Thomas HC
J Hepatol; 1986; 3 Suppl 2():S291-9. PubMed ID: 2439575
[TBL] [Abstract][Full Text] [Related]
26. Randomised controlled trial of adenine arabinoside 5'-monophosphate (ARA-AMP) in chronic hepatitis B virus infection.
Weller IV; Lok AS; Mindel A; Karayiannis P; Galpin S; Monjardino J; Sherlock S; Thomas HC
Gut; 1985 Jul; 26(7):745-51. PubMed ID: 2410328
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis delta virus infection in Taiwan.
Liaw YF; Lin HH; Chu CM; Sheen IS; Huang MJ
Prog Clin Biol Res; 1987; 234():479-83. PubMed ID: 3628418
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis delta virus infection: a recently imported disease in New Zealand.
Ramirez AM; Lee SP; Woodfield DG
N Z Med J; 1987 Apr; 100(822):235-7. PubMed ID: 3454892
[TBL] [Abstract][Full Text] [Related]
29. Alpha 2 recombinant interferon in the treatment of chronic hepatitis delta virus (HDV) hepatitis.
Rosina F; Saracco G; Lattore V; Quartarone V; Rizzetto M; Verme G; Trinchero P; Sansalvadore F; Smedile A
Prog Clin Biol Res; 1987; 234():299-303. PubMed ID: 3628384
[No Abstract] [Full Text] [Related]
30. [Incidence of the HBsAg carrier state among pregnant women and its effect on the newborn infant. II. The presence of hepatitis B and delta markers in the umbilical cord serum of infants born to mothers who are HBsAg carriers].
Iliev B; Stambolov B; Khristov M
Akush Ginekol (Sofiia); 1987; 26(5):22-5. PubMed ID: 3434699
[No Abstract] [Full Text] [Related]
31. Comparative efficacy of adenine arabinoside 5' monophosphate and prednisone withdrawal followed by adenine arabinoside 5' monophosphate in the treatment of chronic active hepatitis type B.
Perrillo RP; Regenstein FG; Bodicky CJ; Campbell CR; Sanders GE; Sunwoo YC
Gastroenterology; 1985 Mar; 88(3):780-6. PubMed ID: 2578421
[TBL] [Abstract][Full Text] [Related]
32. Epidemiological aspects of delta (HDV) infection in a northern Italy district.
Magnani G; Calzetti C; Degli Antoni A; Perinotto P; Pasetti G
Prog Clin Biol Res; 1987; 234():385-7. PubMed ID: 3628392
[No Abstract] [Full Text] [Related]
33. Adenine arabinoside monophosphate in experimental vaccinia virus infections.
Werner GT; Metzger E; Sauer O
Adv Ophthalmol; 1979; 38():72-81. PubMed ID: 93408
[No Abstract] [Full Text] [Related]
34. Infection with hepatitis delta virus in patients with fulminant hepatitis B and chronic HBsAg carriers in Bulgaria.
Naoumov NV; Gueorgiev A; Ognyanov M; Maleev A
Hepatogastroenterology; 1986 Apr; 33(2):49-51. PubMed ID: 3721387
[TBL] [Abstract][Full Text] [Related]
35. [Incidence of the HBsAg carrier state among pregnant women and its effect on newborn infants. I. The incidence of the HBsAg carrier state among pregnant women in different provinces of Bulgaria].
Iliev B; Stambolov B; Khristov M
Akush Ginekol (Sofiia); 1987; 26(4):43-7. PubMed ID: 3674323
[No Abstract] [Full Text] [Related]
36. [Clinical variants of acute delta infection].
Ketiladze ES; Khlopova IN; Bugaeva NP
Klin Med (Mosk); 1988 Aug; 66(8):95-9. PubMed ID: 3193743
[No Abstract] [Full Text] [Related]
37. Infection with the delta agent in chronic HBsAg carriers.
Smedile A; Dentico P; Zanetti A; Sagnelli E; Nordenfelt E; Actis GC; Rizzetto M
Gastroenterology; 1981 Dec; 81(6):992-7. PubMed ID: 7286594
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of delta antigen/antibody in various HBsAg positive patients in Saudi Arabia.
Shobokshi OA; Serebour FE
Prog Clin Biol Res; 1987; 234():471-5. PubMed ID: 2819896
[No Abstract] [Full Text] [Related]
39. Anti-hepatitis delta virus seroprevalence and risk factors in patients with hepatitis B in Southeast Turkey.
Celen MK; Ayaz C; Hosoglu S; Geyik MF; Ulug M
Saudi Med J; 2006 May; 27(5):617-20. PubMed ID: 16680248
[TBL] [Abstract][Full Text] [Related]
40. [The incidence of the HBsAg carrier state among pregnant women and its effect on newborn infants. III. Viral hepatitis morbidity among the infants born to mothers who are HBsAg carriers].
Iliev B; Stambolov B; Khristov M; Marinova E
Akush Ginekol (Sofiia); 1988; 27(4):44-9. PubMed ID: 3218680
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
